排序方式: 共有38条查询结果,搜索用时 15 毫秒
11.
黄氏愈伤贴是在我院已故著名老中医黄乃聪先生所创制的黄氏治伤软膏的基础上,经过处方整理筛选和剂型革新研制而成的一种新型外用药.具有活血化瘀、舒筋活络、消肿止痛等功效,临床应用数十年,深受患者的好评[1].本研究评价黄氏愈伤贴治疗急性软组织损伤患者的有效性及安全性,采用随机消炎止痛膏平行对照,现报道如下. 相似文献
12.
臀上皮神经卡压症是指由于臀上皮神经在髂嵴“入臀点”处的骨纤维管内受到卡压而引发臀痛或臀腿痛的一种症状。多由于腰臀部急性扭伤或慢性劳损引起,本病为骨伤科常见病。作者自2000年以来应用铍针治疗,取得满意效果。 相似文献
13.
Objective To assess the effixacy of a nasally inhaled corticosteroid(ICS) through a spacer with mask aiming at simultaneou treatment of allergic rhinitis and asthma in children and make an analysis on the costs.Method A total of 72 children with allergic rhinitis (AR) and asthma were randomized into two groups.Experimental group received budesonide inhaler(400 μg/d) through the nose using a spacer attached to a face mask,control group children orally inhaled budesonide dry powder (400μg/d) plus a nasal spray of budesonide aquae(256μg/d).Result The patients were obsenred for 12 weeks.The symptom scores of rhinitis of both experimental group and control group declined(F=6.529 and 7.014,all P<0.01),symptom scores of asthma in both group were also reduced(F=4.132 and 4.950,P<0.01).The pulmonary function PEF(L/win)in both groups continuously increased(F=2.750 and 3.282,P<0.05).But the clinical scores,PEF value and FEVl all did not differ between the two groups at admission or at nearly all follow-up visits(P>0.05 for all).The proportion of dry nose was lower in experimental group than in the control group(5.6% vs.19.4%),but the difference was not statistically significant.The cost in the experimental group was lower than that in the control group(P<0.01).Condusion Nasal inhalation of ICS provides a therapeutic strategy for controlling AR and asthula in children,especially it result in higher compliance,lower costs,and fewer side effects. 相似文献
14.
目的 探讨采用面罩储雾罐方式给药,经鼻吸入布地奈德(BUD)气雾剂同步治疗小儿变应性鼻炎并哮喘的临床疗效与成本.方法 将72例中~重度变应性鼻炎并轻一中度持续性哮喘的患儿随机分为实验组和对照组,实验组经面罩储雾罐鼻吸入BUD气雾剂400g/d,对照组经口吸入BUD干粉剂400μg/d联合使用BUD鼻喷雾剂256μg/d.进行哮喘和鼻炎的症状评分,监测第1秒时间肺活量(FEV1)、晨起呼气峰流速值(PEF),并进行治疗成本比较.结果 经过12周的临床观察,实验组和对照组的鼻炎症状评分明显下降(F=6.529和7.014,P均<0.01),两组的哮喘症状评分不断减低(F=4.132和4.950,P均<0.01),实验组和对照组的肺通气功能指标PEF(L/min)逐渐升高(F=2.750和3.282,P均<0.05).但两组间的症状评分、FEV1和PEF在入选时与治疗后的多次随访中比较,差异无统计学意义.实验组鼻腔干燥等副反应的发生率(5.6%)低于对照组(19.4%),但差异无统计学意义.平均治疗费用:实验组(244.0±12.8)元,对照组(403.2±17.6)元,差异有统计学意义(P<0.01).结论 面罩式储雾罐经鼻吸入糖皮质激素可同时有效控制小儿变应性鼻炎和哮喘,并有依从性高、副作用少、花费低等优点,适用于轻~中度持续性哮喘合并变应性鼻炎患儿. 相似文献
15.
Objective To assess the effixacy of a nasally inhaled corticosteroid(ICS) through a spacer with mask aiming at simultaneou treatment of allergic rhinitis and asthma in children and make an analysis on the costs.Method A total of 72 children with allergic rhinitis (AR) and asthma were randomized into two groups.Experimental group received budesonide inhaler(400 μg/d) through the nose using a spacer attached to a face mask,control group children orally inhaled budesonide dry powder (400μg/d) plus a nasal spray of budesonide aquae(256μg/d).Result The patients were obsenred for 12 weeks.The symptom scores of rhinitis of both experimental group and control group declined(F=6.529 and 7.014,all P<0.01),symptom scores of asthma in both group were also reduced(F=4.132 and 4.950,P<0.01).The pulmonary function PEF(L/win)in both groups continuously increased(F=2.750 and 3.282,P<0.05).But the clinical scores,PEF value and FEVl all did not differ between the two groups at admission or at nearly all follow-up visits(P>0.05 for all).The proportion of dry nose was lower in experimental group than in the control group(5.6% vs.19.4%),but the difference was not statistically significant.The cost in the experimental group was lower than that in the control group(P<0.01).Condusion Nasal inhalation of ICS provides a therapeutic strategy for controlling AR and asthula in children,especially it result in higher compliance,lower costs,and fewer side effects. 相似文献
16.
Objective To assess the effixacy of a nasally inhaled corticosteroid(ICS) through a spacer with mask aiming at simultaneou treatment of allergic rhinitis and asthma in children and make an analysis on the costs.Method A total of 72 children with allergic rhinitis (AR) and asthma were randomized into two groups.Experimental group received budesonide inhaler(400 μg/d) through the nose using a spacer attached to a face mask,control group children orally inhaled budesonide dry powder (400μg/d) plus a nasal spray of budesonide aquae(256μg/d).Result The patients were obsenred for 12 weeks.The symptom scores of rhinitis of both experimental group and control group declined(F=6.529 and 7.014,all P<0.01),symptom scores of asthma in both group were also reduced(F=4.132 and 4.950,P<0.01).The pulmonary function PEF(L/win)in both groups continuously increased(F=2.750 and 3.282,P<0.05).But the clinical scores,PEF value and FEVl all did not differ between the two groups at admission or at nearly all follow-up visits(P>0.05 for all).The proportion of dry nose was lower in experimental group than in the control group(5.6% vs.19.4%),but the difference was not statistically significant.The cost in the experimental group was lower than that in the control group(P<0.01).Condusion Nasal inhalation of ICS provides a therapeutic strategy for controlling AR and asthula in children,especially it result in higher compliance,lower costs,and fewer side effects. 相似文献
17.
目的探讨行关节腔注射疗法骨关节炎患者关节感染状况。方法选取2014年1月-2016年12月于医院接受治疗的684例骨关节炎患者为研究对象,按治疗方法分为试验组和对照组,各342例,试验组采用关节腔注射玻璃酸钠治疗,对照组采用关节腔注射糖皮质激素治疗。统计两组患者的关节感染情况,并进行病原菌鉴定及药敏分析及治疗前后生活质量评分。结果治疗后,试验组患者关节感染率为0.88%(3/342)低于对照组12.28%(42/342)(P=0.039);45例感染患者共检出病原菌45株,其中革兰阴性菌22株占48.89%,革兰阳性菌21株占46.67%,真菌2株占4.44%;治疗前,两组患者生活质量综合评定问卷(GQOLI-74)评分差异无统计学意义;治疗后两组患者生活质量均有提升,其中试验组患者生活质量评分为(93.28±2.09)分高于对照组(64.34±5.33)分(P0.001);大肠埃希菌对头孢哌酮/舒巴坦、左氧氟沙星较敏感,肺炎克雷伯菌对左氧氟沙星的敏感性较高,金黄色葡萄球菌和链球菌对利奈唑胺较敏感。结论关节腔注射糖皮质激素可增加患者并发关节感染的概率,而关节腔注射玻璃酸钠对患者的临床治疗效果较好。 相似文献
18.
19.
Kartagener综合征1例 总被引:2,自引:0,他引:2
患儿,男,10岁,反复咳嗽、咯痰9年多。患儿于9年多前受凉之后出现阵发性单声咳,咯黄色粘痰,曾在当地医院先后拟“肺炎”、“支气管扩张”治疗多次病情仍反复。患儿为第2胎,孕7个月,家中顺产。体格发育明显落后于同龄儿童。否认麻疹、水痘病史。谓2年前曾患“肺结核”具有治疗不详。患儿有一兄长,体健。家族中无类似患者。父母非近亲结婚,体健。 相似文献
20.